1,200
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Chiral 4-O-acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen

, , , , , , & show all
Pages 723-735 | Received 03 Mar 2020, Accepted 21 Apr 2020, Published online: 13 May 2020

References

  • Akhlaq M, Khan G, Wahab A, et al. (2011). A simple high-performance liquid chromatographic practical approach for determination of flurbiprofen. J Adv Pharm Tech Res 2:151–5.
  • Ashtikar M, Nagarsekar K, Fahr A. (2016). Transdermal delivery from liposomal formulations – evolution of the technology over the last three decades. J Control Release 242:126–40.
  • Bouwstra J, Dubbelaar F, Gooris G, et al. (1999). The role of ceramide composition in the lipid organisation of the skin barrier. Biochim Biophys Acta 1419:127–36.
  • Can A, Erdal M, Güngör S, Özsoy Y. (2013). Optimization and characterization of chitosan films for transdermal delivery of ondansetron. Molecules 18:5455–71.
  • Chen J, Jiang Q, Wu Y, et al. (2015a). Potential of essential oils as penetration enhancers for transdermal administration of ibuprofen to treat dysmenorrhoea. Molecules 20:18219–36.
  • Chen Y, Quan P, Liu X, et al. (2015b). Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation. J Pharm Pharmacol 67:1232–9.
  • Clouet P, Niot I, Bézard J. (1989). Pathway of α-linolenic acid through the mitochondrial outer membrane in the rat liver and influence on the rate of oxidation. Comparison with linoleic and oleic acids. Biochem J 263:867–73.
  • Cohen-Avrahami M, Libster D, Aserin A, Garti N. (2012). Penetratin-induced transdermal delivery from H II mesophases of sodium diclofenac. J Control Release 159:419–28.
  • Csizmazia E, Erős G, Berkesi O, et al. (2012). Ibuprofen penetration enhance by sucrose ester examined by ATR-FTIR in vivo. Pharm Dev Technol 17:125–8.
  • Ghosh B, Reddy L. (2001). Effect of physicochemical parameters on skin permeability of antihypertensive. Indian J Exp Biol 39:710–14.
  • Guo X, Rong Y, Zhang L, Ye J. (2016). Enhancing effect of chiral enhancer linalool on skin permeation of naproxen. Acta Acad Med Sin 38:55–61.
  • Harada N, Hirano I, Inui H, Yamaji R. (2018). Stereoselective effects of lactate enantiomers on the enhancement of 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 498:105–10.
  • Heard CM, Watkinson AC, Brain KR, Hadgraft J. (1993). In vitro skin penetration of propranolol enantiomers. Int J Pharm 90:5–8.
  • Herman A, Herman A. (2015). Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review. J Pharm Pharmacol 67:473–85.
  • Kesisoglou F, Xia B, Agrawal N. (2015). Comparison of deconvolution-based and absorption modeling IVIVC for extended release formulations of a BCS III drug development candidate. AAPS J 17:1492–500.
  • Kommuru TR, Khan MA, Reddy IK. (1999). Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin. J Chirality 11:536–40. http://101002/(SICI)1520-636X(1999)11:73.0.CO;2-H
  • Li N, Quan P, Wan X, et al. (2017). Mechanistic insights of the enhancement effect of sorbitan monooleate on olanzapine transdermal patch both in release and percutaneous absorption processes. Eur J Pharm Sci 107:138–47.
  • Lin C, Miao Y, Qian M, et al. (2016). Enantioselective metabolism of flufiprole in rat and human liver microsomes. J Agric Food Chem 64:2371–6.
  • Liu C, Farah N, Weng W, et al. (2019). Investigation of the permeation enhancer strategy on benzoylaconitine transdermal patch: the relationship between transdermal enhancement strength and physicochemical properties of permeation enhancer. Eur J Pharm Sci 138:105009.
  • Liu C, Hui M, Quan P, Fang L. (2016). Drug in adhesive patch of palonosetron: effect of pressure sensitive adhesive on drug skin permeation and in vitro-in vivo correlation. Int J Pharm 511:1088–97.
  • Liu X, Liu M, Liu C, et al. (2017a). An insight into the molecular mechanism of the temporary enhancement effect of isopulegol decanoate on the skin. Int J Pharm 529:161–7.
  • Liu X, Quan P, Li S, et al. (2017b). Time dependence of the enhancement effect of chemical enhancers: molecular mechanisms of enhancing kinetics. J Control Release 248:33–44.
  • Masukawa Y, Narita H, Shimizu E, et al. (2008). Characterization of overall ceramide species in human stratum corneum. J Lipid Res 49:1466–76.
  • Miyake M, Burks S, Weaver J, et al. (2010). Comparison of two nitroxide labile esters for delivering electron paramagnetic resonance probes into mouse brain. J Pharm Sci 99:3594–600.
  • Miyazaki K, KAIHO F, INAGAKI A, et al. (1992). Enantiomeric difference in percutaneous penetration of propranolol through rat excised skin. Chem Pharm Bull 40:1075–6.
  • Moore D, Rerek M. (2000). Insights into the molecular organization of lipids in the skin barrier from infrared spectroscopy studies of stratum corneum lipid models. Acta Derm Venereol Suppl (Stockh) 208:16–22.
  • Morimoto Y, Kokubo T, iK S. (1992). Diffusion of drugs in acrylic-type pressure-sensitive adhesive matrix. II. Influence of interaction. J Control Release 18:113–21.
  • Mrózek L, Dvořáková L, Mandelová Z, et al. (2011). Investigation of new acyloxy derivatives of cholic acid and their esters as drug absorption modifiers. Steroids 76:1082–97.
  • Nasompag S, Dechsiri P, Hongsing N, et al. (2015). Effect of acyl chain length on therapeutic activity and mode of action of the C X -KYR-NH 2 antimicrobial lipopeptide. Biochim Biophys Acta 1848:2351–64.
  • Okeke O, Boateng J. (2016). Composite HPMC and sodium alginate based buccal formulations for nicotine replacement therapy. Int J Biol Macromol 91:31–44.
  • Prasad R, Anand S, Khar R, et al. (2009). Studies on in vitro and in vivo transdermal flux enhancement of methotrexate by a combinational approach in comparison to oral delivery. Drug Dev Ind Pharm 35:1281–92.
  • Prasad R, Koul V, Anand S, Khar R. (2007). Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study. Int J Pharm 333:70–8.
  • Reddy IK, Kommuru TR, Zaghloul AAA, Khan MA. (2000). Chirality and its implications in transdermal drug development. J Crit Rev Therap Drug Carrier Syst 17:285–325. http://101615/CritRevTherDrugCarrierSyst.v17.i4.10
  • Rong Y, Yu W, Guo X, et al. (2014). The potential effects of linalool on enantioselective skin permeation of norgestrel. APSB 49:1175–80.
  • Sarroukh R, Goormaghtigh E, Ruysschaert J, Raussens V. (2013). ATR-FTIR: a “rejuvenated” tool to investigate amyloid proteins. Biochim Biophys Acta 1828:2328–38.
  • Song W, Quan P, Li S, et al. (2016). Probing the role of chemical enhancers in facilitating drug release from patches: mechanistic insights based on FT-IR spectroscopy, molecular modeling and thermal analysis. J Control Release 227:13–22.
  • Suedee R, Bodhibukkana C, Tangthong N, et al. (2008). Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane. J Control Release 129:170–8.
  • Tatulian S. (2019). FTIR analysis of proteins and protein-membrane interactions. Methods Mol Biol (2003). 281–325.
  • Valentová J, Bauerová K, Farah L, Devínsky F. (2010). Does stereochemistry influence transdermal permeation of flurbiprofen through the rat skin? Arch Dermatol Res 302:635–8.
  • Vávrová K, Hrabálek A, Doležal P. (2002). Enhancement effects of (R) and (S) enantiomers and the racemate of a model enhancer on permeation of theophylline through human skin. Arch Dermatol Res 294:383–5.
  • Wang E, Klauda J. (2019). Structure and permeability of ceramide bilayers and multilayers. J Phys Chem B 123:2525–35.
  • Wang H, Meng F. (2017). The permeability enhancing mechanism of menthol on skin lipids: a molecular dynamics simulation study. J Mol Model 23:279.
  • Wang W, Song T, Wan X, et al. (2017). Investigate the control release effect of ion-pair in the development of escitalopram transdermal patch using FT-IR spectroscopy, molecular modeling and thermal analysis. Int J Pharm 529:391–400.
  • Yamaguchi K, Mitsui T, Aso Y, Sugibayashi K. (2008). Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin. J Pharm Sci 97:4391–403.
  • Zhang C, Yang Z, Luo J. (2006). Effects of D-limonene and L-limonene on transdermal absorption of ligustrazine hydrochloride. APSB 41:772–7.
  • Zhao L, Fang L, Xu Y, et al. (2008). Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity. Int J Pharm 352:92–103.
  • Zhao L, Li Y, Fang L, et al. (2009). Transdermal delivery of tolterodine by O-acylmenthol: in vitro/in vivo correlation. Int J Pharm 374:73–81.